Etiology, prevalence, and treatment of dry eye disease

Article English OPEN
Gayton, Johnny (2009)
  • Publisher: Dove Press
  • Journal: Clinical Ophthalmology, volume 3, pages 405-412 (issn: 1177-5483, eissn: 1177-5483)
  • Related identifiers: pmc: PMC2720680, doi: 10.2147/OPTH.S5555
  • Subject: prevalence | RE1-994 | Clinical Ophthalmology | postmenopausal women | Original Research | dry eye disease | Ophthalmology | etiology

Johnny L GaytonEyesight Associates, Warner Robins, GA, USAPurpose: This review article examines the prevalence, etiology, and current therapies of dry eye disease, with special focus on postmenopausal women.Method: A systematic literature search utilizing MEDLINE was conducted to identify peer-reviewed articles related to dry eye published prior to September 2008. The terms “dry eye” and “women” were searched in combination with one or more of the following words or phrases: prevalence, postmenopausal, etiology, risk factors, therapy, medications, surgery, tear film, and quality of life. Articles were selected based on their direct applicability to the subject matter. A manual search was also conducted based on citations in the published literature.Results: Epidemiologic studies identified prevalence rates ranging from 7% in the United States to 33% in Taiwan and Japan. Risk factors include advanced age, female sex, smoking, extreme heat or cold weather conditions, low relative humidity, use of video display terminals, refractive surgery, contact lens wear, and certain medications.Conclusion: The last decade has brought about a better understanding of the etiology of dry eye disease. New therapies that can alleviate the signs and symptoms of dry eye disease and, consequently, improve the quality of life of dry eye patients are available in the market.Keywords: dry eye disease, etiology, prevalence, postmenopausal women
  • References (54)
    54 references, page 1 of 6

    1. O'Brien PD, Collum LM. Dry eye: diagnosis and current treatment strategies. Curr Allergy Asthma Rep. 2004;4:314-319.

    2. Sjögren HSC. Zur Kenntnis der Keratoconjunctivitis sicca (Keratitis ifliformis bei Hypofunktion der Tränendrüsen). Acta Ophthalmol. 1933;Supp. II:1-151 Copenhagen.

    3. Murube J. Andrew de Roetth (1893-1981): dacryologist who introduced the term dry eye. Ocul Surf. 2004;2:225-227.

    4. Lemp MA. Report of the National Eye Institute/industry Workshop on clinical trials in dry eye. CLAO J. 1995;21:221-232.

    5. International Dry Eye Workshop (DEWS). The definition and classi - ifcation of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye Workshop. Ocul Surface. 2007;5:75-92.

    6. Foulks GN. Pharmacological management of dry eye in the elderly patient. Drugs Aging. 2008;25:105-118.

    7. Terry MA. Dry eye in the elderly. Drugs Aging. 2001;18:101-107.

    8. Fox RI, Howell FV, Bone RC, et al. Primary Sjögren's syndrome: clinical and immunopathologic features. Semin Arthritis Rheumatol. 1984;14:77-105.

    9. Fairweather D, Frisancho-Kiss S, Rose NR. Sex differences in autoimmune disease from a pathological perspective. Am J Pathol. 2008;173:600-609.

    10. Schaumberg DA, Sullivan DA, Buring JE, et al. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003;136:318-326.

  • Metrics
    views in OpenAIRE
    views in local repository
    downloads in local repository
Share - Bookmark